Curaleaf Reports 4% Sequential Revenue Growth, Exits Hemp and Missouri Markets
Event summary
- Curaleaf expects Q4 2025 net revenue of $330M, up 4% sequentially and 1% YoY.
- Adjusted gross profit margin for Q4 2025 anticipated at 48.5%, matching Q4 2024.
- Company to discontinue hemp business and exit Missouri due to regulatory changes.
- Hemp and Missouri operations contributed ~$2M in revenue in Q3 2025.
- Full-year 2025 adjusted gross margin expected at 50%.
The big picture
Curaleaf's strategic pivot away from hemp and Missouri reflects broader industry consolidation amid tightening regulations. The company's focus on core cannabis markets aligns with a trend toward operational efficiency in the sector. With $330M in expected Q4 revenue, Curaleaf demonstrates resilience in a competitive landscape, though its ability to sustain margins post-restructuring remains a key watchpoint.
What we're watching
- Regulatory Impact
- How federal THC regulations will affect other cannabis operators' hemp divisions.
- Market Focus
- Whether Curaleaf's exit from Missouri signals broader consolidation in sub-scale markets.
- Financial Strategy
- The pace at which Curaleaf completes refinancing of its senior secured notes due December 2026.
Related topics